Detailed information for compound 1627794

Basic information

Technical information
  • TDR Targets ID: 1627794
  • Name: 1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-[(7 -methyl-1H-indazol-5-yl)methyl]-4-[4-(2-oxo-1 ,4-dihydroquinazolin-3-yl)piperidin-1-yl]buta ne-1,4-dione
  • MW: 600.708 | Formula: C33H40N6O5
  • H donors: 2 H acceptors: 4 LogP: 2.03 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C(N1CCC(CC1)N1Cc2ccccc2NC1=O)CC(C(=O)N1CCC2(CC1)OCCO2)Cc1cc(C)c2c(c1)cn[nH]2
  • InChi: 1S/C33H40N6O5/c1-22-16-23(18-26-20-34-36-30(22)26)17-25(31(41)38-12-8-33(9-13-38)43-14-15-44-33)19-29(40)37-10-6-27(7-11-37)39-21-24-4-2-3-5-28(24)35-32(39)42/h2-5,16,18,20,25,27H,6-15,17,19,21H2,1H3,(H,34,36)(H,35,42)
  • InChiKey: SOQUHMYZFBIDNN-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-[(7-methyl-1H-indazol-5-yl)methyl]-4-[4-(2-oxo-1,4-dihydroquinazolin-3-yl)-1-piperidyl]butane-1,4-dione
  • 1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-2-[(7-methyl-1H-indazol-5-yl)methyl]-4-[4-(2-oxo-1,4-dihydroquinazolin-3-yl)-1-piperidinyl]butane-1,4-dione
  • 1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-4-[4-(2-keto-1,4-dihydroquinazolin-3-yl)-1-piperidyl]-2-[(7-methyl-1H-indazol-5-yl)methyl]butane-1,4-dione

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens calcitonin receptor-like Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c calcitonin receptor-like 461 aa 434 aa 28.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium ulcerans polyketide synthase Pks13 0.0867 0.7486 1
Toxoplasma gondii type I fatty acid synthase, putative 0.0616 0.4773 1
Trichomonas vaginalis conserved hypothetical protein 0.0175 0 0.5
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.0467 0.3157 0.4188
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsE 0.0383 0.2258 0.2981
Mycobacterium tuberculosis Probable polyketide synthase Pks8 0.0474 0.324 0.4329
Mycobacterium tuberculosis Polyketide synthase Pks2 0.0562 0.4191 0.5599
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC 0.0616 0.4773 0.6337
Mycobacterium tuberculosis Probable polyketide synthase Pks5 0.0562 0.4191 0.5599
Toxoplasma gondii beta-ketoacyl synthase, N-terminal domain-containing protein 0.0376 0.218 0.2574
Mycobacterium ulcerans polyketide synthase 0.058 0.4383 0.5834
Loa Loa (eye worm) AMP-binding enzyme family protein 0.0542 0.3971 0.3889
Mycobacterium ulcerans polyketide synthase 0.0616 0.4773 0.6357
Brugia malayi AMP-binding enzyme family protein 0.0542 0.3971 0.3971
Mycobacterium ulcerans polyketide synthase Pks9 0.0383 0.2258 0.2981
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.058 0.4383 0.5856
Mycobacterium tuberculosis Polyketide synthetase MbtD (polyketide synthase) 0.0178 0.0039 0.0052
Onchocerca volvulus Fatty acid synthase homolog 0.1045 0.9418 1
Mycobacterium tuberculosis Probable polyketide synthase Pks1 0.0417 0.2616 0.3495
Mycobacterium tuberculosis Probable fatty acid synthase Fas (fatty acid synthetase) 0.0182 0.0081 0.0108
Mycobacterium leprae Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas 0.0616 0.4773 0.6337
Onchocerca volvulus 0.1009 0.9028 0.9285
Mycobacterium tuberculosis Probable thioesterase TesA 0.0483 0.3337 0.4459
Giardia lamblia Methyltransferase like 2 0.0175 0 0.5
Mycobacterium tuberculosis Polyketide synthase Pks12 0.0616 0.4773 0.6376
Mycobacterium tuberculosis Probable polyketide synthase Pks9 0.033 0.1676 0.224
Mycobacterium tuberculosis Probable multifunctional mycocerosic acid synthase membrane-associated Mas 0.0616 0.4773 0.6376
Mycobacterium tuberculosis Polyketide synthase Pks13 0.0867 0.7486 1
Mycobacterium ulcerans Type I modular polyketide synthase 0.058 0.4383 0.5834
Schistosoma mansoni methyltransferase-related 0.0175 0 0.5
Mycobacterium ulcerans thioesterase 0.0483 0.3337 0.443
Mycobacterium tuberculosis Probable polyketide synthase Pks15 0.0234 0.0647 0.0864
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsB 0.0467 0.3157 0.4188
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD 0.058 0.4383 0.581
Mycobacterium ulcerans multifunctional mycocerosic acid synthase membrane-associated Mas 0.0616 0.4773 0.6357
Loa Loa (eye worm) fatty acid synthase 0.0572 0.43 0.4318
Brugia malayi AMP-binding enzyme family protein 0.0178 0.0039 0.0039
Mycobacterium leprae Probable polyketide synthase Pks1 0.0616 0.4773 0.6337
Mycobacterium ulcerans Type I modular polyketide synthase 0.058 0.4383 0.5834
Mycobacterium tuberculosis Probable polyketide synthase Pks7 0.0616 0.4773 0.6376
Loa Loa (eye worm) hypothetical protein 0.0974 0.8648 1
Toxoplasma gondii type I fatty acid synthase, putative 0.0413 0.2576 0.3708
Mycobacterium leprae PROBABLE THIOESTERASE TESA 0.0483 0.3337 0.4398
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE 0.0383 0.2258 0.2941
Brugia malayi Beta-ketoacyl synthase, N-terminal domain containing protein 0.058 0.4383 0.4383
Mycobacterium tuberculosis Polyketide synthetase MbtC (polyketide synthase) 0.0199 0.0267 0.0356
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsD 0.058 0.4383 0.5834
Loa Loa (eye worm) hypothetical protein 0.0325 0.1625 0.0823
Mycobacterium ulcerans phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.0616 0.4773 0.6357
Mycobacterium tuberculosis Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) 0.0542 0.3971 0.5305
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsA 0.058 0.4383 0.5856
Leishmania major hypothetical protein, conserved 0.0175 0 0.5
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB 0.0467 0.3157 0.4155
Mycobacterium ulcerans fatty acid synthase Fas 0.0182 0.0081 0.0056
Mycobacterium leprae Polyketide synthase Pks13 0.0867 0.7486 1
Mycobacterium ulcerans Type I modular polyketide synthase 0.058 0.4383 0.5834
Mycobacterium tuberculosis Probable membrane bound polyketide synthase Pks6 0.0867 0.7486 1
Mycobacterium ulcerans thioesterase TesA 0.0483 0.3337 0.443
Mycobacterium tuberculosis Phenolpthiocerol synthesis type-I polyketide synthase PpsC 0.058 0.4383 0.5856
Mycobacterium leprae PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA 0.058 0.4383 0.581

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 3.2 nM Displacement of [125]CGRP from human CGRP receptor expressed in human SK-N-MC cell membrane after 2 hrs by scintillation counting ChEMBL. 22429471
IC50 (functional) = 5.8 nM Antagonist activity at human CGRP receptor expressed in human SK-N-MC cells assessed as inhibition of CGRP-stimulated cAMP production ChEMBL. 22429471

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.